menu
    • menu

    Company profile for Oncotelic Therapeutics

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV...
    Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Oncotelic, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single agent activity in relapsed/refractory cancer patients in clinical trial settings. OT-101 also has activity against SARS-CoV-2. Mateon/Oncotelic is seeking to leverage its deep expertise in drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare pediatric cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncotelic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    29397 Agoura road, Suite 107, Agoura hills CA 91301
    Telephone
    Telephone
    6506357000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncotelic.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncotelic/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Oncotelic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncotelic advances AI-enabled robotics platform
    Oncotelic advances AI-enabled robotics platform

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284873/0/en/oncotelic-therapeutics-advances-toward-commercial-launch-of-ai-enabled-robotics-platform-following-integration-of-28-million-scientific-abstracts.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Oncotelic Therapeutics Updates Partnership Strategy
    Oncotelic Therapeutics Updates Partnership Strategy

    24 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7206630

    FIRSTWORD PHARMA
    24 Apr 2026
    Share Share
    Oncotelic Therapeutics Show Real-World Scientific Progress Impact
    Oncotelic Therapeutics Show Real-World Scientific Progress Impact

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279905/0/en/oncotelic-therapeutics-inc-otcqb-otlc-real-world-example-of-scientific-advancement-influence-on-evaluation.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Oncotelic Boosts Compliance with AI-Driven Technology
    Oncotelic Boosts Compliance with AI-Driven Technology

    10 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/10/3271722/0/en/Oncotelic-Therapeutics-Inc-OTCQB-OTLC-Strengthening-Position-with-AI-Driven-Tech-in-Automated-Compliance-Space.html

    GLOBENEWSWIRE
    10 Apr 2026
    Share Share
    Oncotelic Partners with TechForce Robotics for GMP Platform
    Oncotelic Partners with TechForce Robotics for GMP Platform

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267346/0/en/Oncotelic-Therapeutics-Announces-Strategic-Partnership-with-TechForce-Robotics-to-Commercialize-PDAOAI-Enhanced-GMP-Robotics-Platform.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Sapu Nano Launches Deciparticle Platform at BIO-Europe Spring
    Sapu Nano Launches Deciparticle Platform at BIO-Europe Spring

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261147/0/en/Sapu-Nano-to-Launch-Deciparticle-Platform-and-Present-Clinical-Pipeline-at-BIO-Europe-Spring-2026.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search